Showing results (231-240 of 310) with videos related to

Sort By:
Pageof 31
Science (New York, N.Y.)|March 2, 2021
Targeting a neoantigen derived from a common TP53 mutationEmily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
The New England Journal of Medicine|June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon CancerJeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.
Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cellsJin Liu, Yuanxuan Xia, Brian J Mog, et al.
Nature Medicine|October 20, 2025
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trialJeanne Tie, Yuxuan Wang, Jonathan M Loree, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
TCR-mimic bispecific antibodies to target the HIV-1 reservoirSrona Sengupta, Nathan L Board, Fengting Wu, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
Pageof 31